Jun 18, 2024, 18:23
Matthias Guckenberger: Cancer trial participation not associated with longer OS compared to routine care
Matthias Guckenberger, Radiation Oncologist at University Hospital Zurich, shared on X:
“Cancer trial participation not associated with longer OS compared to routine care.
Motivation for patients:
- Potential benefits other than OS eg structured care protocols.
- To contribute to a better treatment for FUTURE patients.”
Additional information.
Source: Matthias Guckenberger/X
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Jan 6, 2025, 13:02
Jan 6, 2025, 12:59
Jan 6, 2025, 12:33
Jan 6, 2025, 12:31
Jan 6, 2025, 12:31
Jan 6, 2025, 11:54